Search

Your search keyword '"Sorensen, Poul H."' showing total 750 results

Search Constraints

Start Over You searched for: Author "Sorensen, Poul H." Remove constraint Author: "Sorensen, Poul H."
750 results on '"Sorensen, Poul H."'

Search Results

3. Engineered CD47 protects T cells for enhanced antitumour immunity

5. Early rhombic lip Protogenin+ve stem cells in a human-specific neurovascular niche initiate and maintain group 3 medulloblastoma

6. Oncogenic ETS fusions promote DNA damage and proinflammatory responses via pericentromeric RNAs in extracellular vesicles

7. Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication

8. Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours

9. Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma

10. Failure of human rhombic lip differentiation underlies medulloblastoma formation

11. MondoA drives malignancy in B-ALL through enhanced adaptation to metabolic stress

13. Author Correction: The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner

14. Optineurin links Hace1-dependent Rac ubiquitylation to integrin-mediated mechanotransduction to control bacterial invasion and cell division

18. Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma

19. Author Correction: Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma

20. Eukaryotic Elongation Factor 2 Kinase EFK-1/eEF2K promotes starvation resistance by preventing oxidative damage inC. elegans

21. Supplementary Figure S14 from Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma

22. Data from Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma

23. Supplementary Data S3 from Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma

24. Supplementary Table S1 from Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma

28. Current state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop

30. Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors

31. Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation

33. Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma

35. A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma

36. A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma

37. Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma

42. Supplementary Material and Methods S1 from A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma

43. Supplementary Figure S5 from A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma

44. Data from A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma

45. Supplementary Table S1 from A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma

46. A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN -amplified neuroblastoma

49. A homing system targets therapeutic T cells to brain cancer

Catalog

Books, media, physical & digital resources